| Primary information |
|---|
| ID | 15849 |
| Uniprot ID | Q8NG41 |
| Description | Neuropeptide B/W family |
| Organism | Homo sapiens |
| Txonomy | Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata (jawed vertebrates); Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Mammalia; Theria; Eutheria; Boreoeutheria; Euarchontoglires; Primates; Haplorrhini; Simiiformes; Catarrhini; Hominoidea (apes); Hominidae (great apes); Homininae; Homo; Homo sapiens (Human) |
| Subcellular Location | secreted |
| Developmental Stage | Widely expressed in the central nervous system. High levels are found in substantia nigra; hypothalamus; hyppocampus; spinal cord; placenta and fetal brain; lower levels are found in testis; uterus an |
| Similarity | Neuropeptide B/W family |
| Tissue Specificity | Widely expressed in the central nervous system. High levels are found in substantia nigra; hypothalamus; hyppocampus; spinal cord; placenta and fetal brain; lower levels are found in testis; uterus an |
| Post Translational Modification | NA |
| Function | May be involved in the regulation of feeding; neuroendocrine system; memory; learning and in the afferent pain pathway |
| Length | 24 |
| Molecular Weight | 0 |
| Name | Neuropeptide B-23 |
| Sequence | WYKPAAGHSSYSVGRAAGLLSGLR |
| Sequence map | NA |
| PDB ID | NA |
| Drugpedia | NA |
| Receptor | P48145; P48146; P48145; P48146 |
| Domain | NA |
| Pharmaceutical Use | NA
|